ABSTRACT A 10-kilobase DNA fragment containing exons 1 and 2 of the chicken lysozyme gene has been randomly cleaved with DNase I. After tailing and cloning into the plasmid pUK230, Lac' colonies were selected. Colonies harboring expressed fragments of the exons could be detected by an immunoenzymatic assay using antibodies against lysozyme. The smallest fragment coded for 10 amino acids and the largest coded for almost all residues ofexon 2. These results suggest that any gene ofany genome cloned in this way can be detected if antibodies against the gene product are available.
by the product such a fragment encodes (6) . The gene fragments are cloned so that when they are expressed in E. coli their protein products are fused as NH2-terminal peptides to /3-galactosidase, thus stabilizing these protein products. The identification of colonies containing such chimeras was done by a variation of the antibody test used by Broome and Gilbert (7) . The average length of eukaryotic exons is 100-200 bp. Their identification with the immunoenzymatic method thus should be possible after cloning of genomic DNA fragments 100-200 bp long. As a consequence, any eukaryotic gene could be directly cloned and identified ifantibodies against the gene product were available.
To examine the possibilities of the method, we used a genomic DNA fragment from the chicken containing exon 1 and 2 ofthe lysozyme gene, the structure ofwhich is well established (8) .
MATERIALS AND METHODS
Strains and Plasmids. E. coli K-12 BMH 71-18 (A[lac pro] thi suIl F'lac IQZ M15 pro') (9), pUR2 (10) , and pUK230 (6) have been described, as have pls-1 (11) and Xlys3l (12) .
Enzymes. Restriction endonucleases BamHI (New England BioLabs) and EcoRI and Pst I (Boehringer Mannheim) were used as described (13) . DNA polymerase I (large fragment) was purchased from Bethesda Research Laboratories and terminal deoxyribonucleotidyltransferase was from P-L Biochemicals.
The tailing reactions were done as described in ref.
14. Antibodies. Rabbit antibodies against lysozyme were prepared with 0.1% NaDodSO4-denatured electrophoretically purified lysozyme as the immunogen (Merck, Darmstadt, Federal Republic of Germany). They were purified from the sera as described (15 (12) was cloned into the plasmid pUR2. The resultant plasmidpUR2-E7.0 contains exons 1 and 2 (El and E2) of the lysozyme gene. The vector pUK230 carries a frameshift mutation in the polylinker region (codons 5 and 6 of the lac Z gene). This reduces the background of plasmids without insert after tailing and annealing with the dC-tailed fragments. The plasmids of Lac' colonies must carry an insert as demonstrated by the plasmid pUK230-LyD. Thus, normally the chimeric protein begins with amino acid residues 1-5 of 3galactosi-dase followed by a poly (Gly) stretch (GGG)n, followed by the residues encoded by the inserted DNA fragments, followed by a poly (Pro) stretch (CCC)n and residues 6-1,021 of f-galactosidase.
NaClO4 (final concentration, 1 M). The solution was extracted twice with chloroform, and the DNA was collected by the addition of 0.5-vol of isopropanol and centrifugation for 5 min at 15,000 rpm (27,000 x g). The dried pellet was dissolved in 100
Aul of DNA buffer (10 mM Tris-HCl/1 mM EDTA, pH 7.6); 10 ,ul of this DNA solution (0.5-1 Ag) was digested with Pst I and EcoRI. Labeling, separation, and elution of the fragment was carried out as described (13) . DNA sequence analysis was as described in ref. 16 . RESULTS Construction and Identification of a Clone Containing Lysozyme cDNA. The general scheme of the construction of the clones is shown in Fig. 1 . The vector pUK230 (6) was cut with BamHI in the promoter proximal region of the lac Z gene. Insertions in this region do not abolish activity of P-galactosidase (17) . The dC-tailed fragment was annealed with the dG-tailed vector. A Lac-E. coli strain was transformed and Lac' bacteria were selected for. If the fragment contained no stop codon in phase and ifit was inserted in the frame of/3-galactosidase, Lac' clones should arise. After lysis ofcolonies, a plastic sheet coated with antibodies-in our case, against lysozyme-was used to detect positive colonies. Because only those /3-galactosidase molecules that contain covalently bound antigen adhere to the antibody-coated plastic, the position ofsuch clones can be readily visualized. A colorless substrate of /3-galactosidase can be hydrolyzed to an insoluble colored (in our case blue) product.
For a first test ofthe antigenicity ofa product made in E. coli, we constructed a clone that contained the major part of the chicken lysozyme mRNA sequence. We cloned the Alu I DNA fragment of a cDNA clone coding for amino acid residues 8-84 ofthe lysozyme (11) after dC tailing in the dG-tailed BamHI site of vector pUK230. The DNA was transformed after annealing in the E. coli strain BMH 71-18 (a Lac-strain) (9) . Lac' colonies were tested for the presence of expressed parts of the lysozyme gene with lysozyme-specific antibodies. Details of the test are described in ref. 6 . Plasmid DNA from positive colonies was isolated and the sequences of the inserts were determined. All clones harbored the expected Alu I DNA fragment in the correct reading frame. We used one ofthese clones as a positive control in the determination of the antigenicity of the genomic clones.
Construction and Identification of Clones Containing Fragments of Exon 1 or 2 of the Chicken Lysozyme Gene. The general scheme of the construction was the same as above (Fig. 1) . The positions in the genomic DNA sequence of the fragments that we found to give rise to antigenically active products are presented in Fig. 3 , together with a partial sequence of the region of the part of the lysozyme gene we used in these exper- (Fig. 4) . The antigenic strength of all these positive clones, measured as intensity of the blue color on the plastic sheets, was comparable to that of the cDNA clone and thus independent of the size of the fragment.
Analysis of Lac' Clones by Colony Hybridization. We reasoned that not all expressed exon DNA fragments might be detected by the immunoenzymatic screening method because not all fragments ofthis region capable ofexpression might carry an antigenic determinant. To get a rough idea of the frequency of such clones we used the method of colony hybridization (2) . As a hybridization probe we used the lysozyme cDNA insert of plasmid pls-l (11). We tested the 588 Lac' clones screened previously and found 4 additional clones containing exon DNA (Table 1) . We subjected three ofthese clones to sequence analysis. Two were identical; they carried a DNA fragment of exon 1 in the opposite orientation but no stop codon in the /3-galactosidase frame. The other clone contained a DNA fragment of exon 2 in the correct orientation but not in the frame of the lysozyme gene (Fig. 3) . The lengths ofthese DNA fragments were 87 and 82 bp.
DISCUSSION
Our results suggest the possibility of cloning and identifying directly fragments of exons from a genomic library without a nucleic acid probe. In the immunoenzymatic test 6 clones from 6,758 transformants were shown to contain parts ofthe lysozyme gene (Table 1) . Thus, we found 1 specific clone among almost 103 transformants. We did the experiment with a 104-bp fragment. The genome of the malaria parasite Plasmodium falciparum contains about 107 bp. Thus, it would be necessary to screen at least 106 transformants (103 X 103) if one wanted to detect a particular DNA sequence in this eukaryotic genome. But less than 105 of these 106 clones would be Lac' and only these have to be tested with the appropriate antibodies.
In our experiment we found about 10% of the clones to be Lac'. If we were to perform the experiment with higher euProc. Natl. Acad. Sci. USA 79 (1982) Proc. Natl. Acad. Sci. USA 79 (1982) Previous analysis of lysozyme suggested that at least some ofits antigenic sites were composed ofamino acid residues from different parts ofthe protein but not from a contiguous sequence (19) . Cloning and expression offragments of the lysozyme gene would not regenerate such structures and thus detection of these determinants with antibodies should be impossible. Because in our experiment with genomic lysozyme DNA we could demonstrate the opposite, this must mean that not all antigenic determinants of lysozyme are of this type. This is in line with some recent results (20) .
One clone showed that 30 bp of exon DNA suffice for identification with antibodies. In one case the known three-dimensional structure of lysozyme suggests that the region is in the conformation of an a-helix; in the other case this is likely (Fig.  3) .
The coding sequences for every individual contiguous antigenic site recognized by a series of monoclonal antibodies thus may be determined by this method. This is of interest because monoclonal antibodies that affect protein function could be used to identify the subdomain of the protein involved. The method may be also used for the production ofvaccines. Small antigenic sites could be determined and then synthesized. After coupling to an insert carrier they could be used directly for vaccination. Finally, unknown targets in autoimmune diseases could be determined.
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